Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients

被引：42
|
作者：
Shen, Yong [1 ,2 ]
Zhang, Suzhan [1 ,2 ]
Sun, Ren [1 ,2 ,3 ]
Wu, Tingting [1 ,2 ,3 ]
Qian, Jing [2 ,4 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc,China Natl Minist Educ,Key Lab Canc Pre, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, ZJU UCLA Joint Ctr Med Educ & Res, Hangzhou 310058, Zhejiang, Peoples R China
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[4] Zhejiang Univ, Sch Med, Res Ctr Infect & Immun, Hangzhou 310058, Zhejiang, Peoples R China
来源：
EMERGING MICROBES & INFECTIONS | 2015年 / 4卷
基金：
中国国家自然科学基金;
关键词：
adaptive immunity; EBV; immune evasion; innate immunity; NPC; NASOPHARYNGEAL CARCINOMA-CELLS; REGULATORY T-CELLS; MEMBRANE-PROTEIN; NF-KAPPA-B; ANTIGEN-PROCESSING FUNCTION; BURKITTS-LYMPHOMA CELLS; CLASS-II EXPRESSION; COMPLEX CLASS-I; DENDRITIC CELLS; LATENT MEMBRANE-PROTEIN-1;
D O I：
10.1038/emi.2015.20
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Epstein-Barr virus (EBV) has been used as a paradigm for studying host-virus interactions, not only because of its importance as a human oncogenic virus associated with several malignancies including nasopharyngeal carcinoma (NPC) but also owing to its sophisticated strategies to subvert the host antiviral responses. An understanding of the interplay between EBV and NPC is critical for the development of EBV-targeted immunotherapy. Here, we summarize the current knowledge regarding the host immune responses and EBV immune evasion mechanisms in the context of NPC.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] EPSTEIN-BARR VIRUS LOAD IN CEREBROSPINAL FLUID OF PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION
    Ohga, Shouichi
    Sanefuji, Masafumi
    Ishimura, Masataka
    Nomura, Akihiko
    Torisu, Hiroyuki
    Kira, Ryutaro
    Takada, Hidetoshi
    Mizuno, Yumi
    Kazuyama, Yukumasa
    Hara, Toshiro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (11) : 1027 - 1030
  • [22] Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis
    Ciccocioppo, Rachele
    Mengoli, Caterina
    Betti, Elena
    Comolli, Giuditta
    Cassaniti, Irene
    Piralla, Antonio
    Kruzliak, Peter
    Caprnda, Martin
    Pozzi, Lodovica
    Corazza, Gino Roberto
    Di Sabatino, Antonio
    Baldanti, Fausto
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (03) : 379 - 388
  • [23] EPSTEIN-BARR VIRUS
    BRICOUT, F
    REVUE DU PRATICIEN, 1980, 30 (03): : 131 - 135
  • [24] Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis
    Rachele Ciccocioppo
    Caterina Mengoli
    Elena Betti
    Giuditta Comolli
    Irene Cassaniti
    Antonio Piralla
    Peter Kruzliak
    Martin Caprnda
    Lodovica Pozzi
    Gino Roberto Corazza
    Antonio Di Sabatino
    Fausto Baldanti
    Clinical and Experimental Medicine, 2021, 21 : 379 - 388
  • [25] Epstein-Barr Virus
    Nowalk, Andrew
    Green, Michael
    MICROBIOLOGY SPECTRUM, 2016, 4 (03):
  • [26] Epstein-Barr virus
    Junker, AK
    PEDIATRICS IN REVIEW, 2005, 26 (03) : 79 - 84
  • [27] The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease
    Olivia L. Hatton
    Aleishia Harris-Arnold
    Steven Schaffert
    Sheri M. Krams
    Olivia M. Martinez
    Immunologic Research, 2014, 58 : 268 - 276
  • [28] CURRENT UNDERSTANDING OF THE ROLE OF EPSTEIN-BARR VIRUS IN LYMPHOMAGENESIS
    Kimura, Hiroshi
    ANNALS OF ONCOLOGY, 2014, 25
  • [29] EPSTEIN-BARR VIRUS
    SCHOOLEY, RT
    CURRENT OPINION IN INFECTIOUS DISEASES, 1989, 2 (02) : 267 - 271
  • [30] EPSTEIN-BARR VIRUS
    HENLE, W
    HENLE, G
    LENNETTE, ET
    SCIENTIFIC AMERICAN, 1979, 241 (01) : 48 - &
12345